The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2020

Filed:

Aug. 15, 2016
Applicants:

Northeastern University, Boston, MA (US);

Dana-farber Cancer Institute, Inc., Boston, MA (US);

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

Wilfred Ngwa, Orlando, FL (US);

Rajiv Kumar, Malden, MA (US);

Gerassimos Makrigiorgos, Chestnut Hill, MA (US);

Srinivas Sridhar, Newton, MA (US);

Stephanie Dougan, Boston, MA (US);

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 41/00 (2020.01); A61N 5/10 (2006.01); A61K 47/69 (2017.01); A61K 49/04 (2006.01); A61K 39/00 (2006.01); C07K 16/28 (2006.01); A61N 5/06 (2006.01); A61N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 41/0038 (2013.01); A61K 39/00 (2013.01); A61K 47/6923 (2017.08); A61K 47/6929 (2017.08); A61K 49/0428 (2013.01); A61N 5/1007 (2013.01); C07K 16/2878 (2013.01); A61N 5/062 (2013.01); A61N 7/00 (2013.01); A61N 2005/1019 (2013.01); A61N 2005/1089 (2013.01); A61N 2005/1098 (2013.01);
Abstract

Compositions and methods for the radiological and immunotherapeutic treatment of cancer are provided. Metallic nanoparticles conjugated with an immunoadjuvant are dispersed within a biodegradable polymer matrix that can be implanted in a patient and released gradually. The implant may be configured as, or be a component of, brachytherapy spacers and applicators, or radiotherapy fiducial markers. The composition may be combined with marginless radiotherapy, allowing for lower doses of radiation and enhancing the immune response against cancer, including at non-irradiated sites.


Find Patent Forward Citations

Loading…